title: Benefit-risk analysis: examples using quantitative methods.
authors.affiliation: Aventis Pharmaceuticals, Bridgewater, NJ, USA. William.Holden@aventis.com
authors.forename: William L
authors.initials: WL
authors.lastname: Holden
authors.forename: Juhaeri
authors.initials: J
authors.lastname: Juhaeri
authors.forename: Wanju
authors.initials: W
authors.lastname: Dai
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001943:Breast Neoplasms / Q000188:drug therapy; D005260:Female; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D018570:Risk Assessment / Q000379:methods*
chemical_list: D018501:Antirheumatic Agents